| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.17 | 0.05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |